These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1372661)

  • 1. Effect of recombinant human granulocyte colony-stimulating factor in patients receiving chemotherapy for urogenital cancer. Urological rhG-CSF Study Group.
    Aso Y; Akaza H
    J Urol; 1992 Apr; 147(4):1060-4. PubMed ID: 1372661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Optimal way of administration of granulocyte colony stimulating factor in the treatment of urological cancer].
    Okaneya T; Tsuruta T; Niwakawa M; Kawakami M; Kobayashi S; Ogawa A
    Nihon Hinyokika Gakkai Zasshi; 1993 Apr; 84(4):680-5. PubMed ID: 7684099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escalated dosages of methotrexate, vinblastine, doxorubicin, and cisplatin plus recombinant human granulocyte colony-stimulating factor in advanced urothelial carcinoma: an Eastern Cooperative Oncology Group trial.
    Loehrer PJ; Elson P; Dreicer R; Hahn R; Nichols CR; Williams R; Einhorn LH
    J Clin Oncol; 1994 Mar; 12(3):483-8. PubMed ID: 7509853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M-VEC (methotrexate, vinblastine, epirubicin, and cisplatin) with granulocyte colony-stimulating factor for the treatment of urothelial cancer: an effective and safe chemotherapy regimen.
    Igawa M; Kadena H; Ueda M; Usui T
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S1-4. PubMed ID: 7527732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-intensification of MVAC with recombinant granulocyte colony-stimulating factor as initial therapy in advanced urothelial cancer.
    Seidman AD; Scher HI; Gabrilove JL; Bajorin DF; Motzer RJ; O'Dell M; Curley T; Dershaw DD; Quinlivan S; Tao Y
    J Clin Oncol; 1993 Mar; 11(3):408-14. PubMed ID: 7680373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schedule-intensified M-VAC chemotherapy for advanced urothelial cancer with recombinant human granulocyte colony stimulating factor (rhG-CSF).
    Noguchi S; Kubota Y; Shuin T; Hosaka M; Miura T; Kondoh I
    Int J Urol; 1994 Jun; 1(2):140-2. PubMed ID: 7543010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escalated M-VAC chemotherapy and recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) in patients with advanced urothelial tract tumors.
    Sternberg CN; de Mulder PH; van Oosterom AT; Fossa SD; Giannarelli D; Soedirman JR
    Ann Oncol; 1993 May; 4(5):403-7. PubMed ID: 8353075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of methotrexate, vinblastine, doxorubicin and cisplatin plus recombinant human granulocyte-macrophage colony stimulating factors in patients with advanced transitional cell carcinoma.
    Moore MJ; Iscoe N; Tannock IF
    J Urol; 1993 Oct; 150(4):1131-4. PubMed ID: 8371371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer--phase I/II study.
    Yoshida O; Kakehi Y; Arai Y; Tomoyoshi T; Okada Y; Matsuda T; Mikami O; Fukuyama T; Hida S; Okabe T
    Int J Urol; 1995 Nov; 2(5):316-21. PubMed ID: 8749950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M-VEC (methotrexate, vinblastine, 4'-epirubicin and cisplatin) combined with glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the treatment of transitional cell carcinoma of urothelium: reduction in toxicity produced by rhG-CSF.
    Ueda M; Igawa M; Kadena H; Usui T
    Int J Urol; 1994 Sep; 1(3):223-7. PubMed ID: 7542154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of recombinant human granulocyte colony stimulating factor in patients with transitional cell carcinoma of the urothelium receiving methotrexate, etoposide and cisplatinum combination chemotherapy].
    Miura T; Murai T; Shimura H; Kondo I
    Hinyokika Kiyo; 1993 Mar; 39(3):209-12. PubMed ID: 7685138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial of recombinant granulocyte colony-stimulating factor for chemotherapy-induced neutropenia patients with oral cancer.
    Iwase M; Yoshiya M; Kakuta S; Nagumo M
    J Oral Maxillofac Surg; 1997 Aug; 55(8):836-40; discussion 841. PubMed ID: 9251612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of recombinant human granulocyte colony stimulating factor on dose intensity and toxicity of three cycles of methotrexate, vinblastine, doxorubicin and cisplatin in patients with previously untreated urothelial bladder carcinoma.
    Viens P; Gravis G; Bladou F; Lechevallier E; Baume D; Camerlo J; Cowen D; Coulange C; Serment G; Resbeut M; Maraninchi D
    Eur Cytokine Netw; 1996 Sep; 7(3):395-9. PubMed ID: 8954183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium.
    Gabrilove JL; Jakubowski A; Scher H; Sternberg C; Wong G; Grous J; Yagoda A; Fain K; Moore MA; Clarkson B; Oettgen HF; Alton K; Welte K; Souza L
    N Engl J Med; 1988 Jun; 318(22):1414-22. PubMed ID: 2452983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse effect on bone marrow protection of prechemotherapy granulocyte colony-stimulating factor support.
    de Wit R; Verweij J; Bontenbal M; Kruit WH; Seynaeve C; Schmitz PI; Stoter G
    J Natl Cancer Inst; 1996 Oct; 88(19):1393-8. PubMed ID: 8827017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Granulocyte function of patients on anti-cancer chemotherapy].
    Okada H; Miyazaki J; Kamidono S
    Nihon Hinyokika Gakkai Zasshi; 1994 Jun; 85(6):958-63. PubMed ID: 7520515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of recombinant human granulocyte colony stimulating factor (rhG-CSF) on leukopenia induced by chemotherapy in cancer patients].
    Shi YK; Zhou JC; Feng FY
    Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):207-10. PubMed ID: 7525173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of recombinant human granulocyte colony-stimulating factor (RHG-CSF) on leucopenia induced by chemotherapy with CE regimen on lung cancer patients].
    Shi YK; Feng FY; Sun Y
    Zhonghua Nei Ke Za Zhi; 1994 Nov; 33(11):739-42. PubMed ID: 7541325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of recombinant human granulocyte colony-stimulating factor on superoxide production by neutrophil in cancer patients receiving chemotherapy].
    Yoshida M; Oshi M; Aso Y; Yanagisawa R; Kishi H; Ishida Y
    Nihon Hinyokika Gakkai Zasshi; 1993 Jul; 84(7):1262-8. PubMed ID: 7689123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute arterial thrombosis after escalated-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy with recombinant granulocyte colony-stimulating factor. A possible new recombinant granulocyte colony-stimulating factor toxicity.
    Conti JA; Scher HI
    Cancer; 1992 Dec; 70(11):2699-702. PubMed ID: 1384952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.